Even though American Convey Corporation (NYSE: AXP) has exhibited resilience and executed nicely throughout the COVID-19 pandemic, there are concerns close to the “near-to-medium time period billing volumes, notably airline and lodging invest,” in accordance to BofA Securities.
The American Categorical Analyst: Mihir Bhatia downgraded American Convey from Neutral to Underperform and lessened the price concentrate on from $106 to $95.
The American Convey Takeaways: Airline and lodging shell out is at simply 16% of 2019 billing volumes, and AmEx has superior exposure to this phase, Bhatia explained in the Wednesday downgrade take note.
“BofA Sector Analysts estimate it could be 2024 in advance of expending volumes on airlines and lodging are at 2019 concentrations, and a complete restoration is dependent on a vaccine staying readily available and greatly administered,” the analyst explained.
Journey could continue being as an overhang for the company’s billings advancement in the close to-to-medium term, and prolonged weakness in vacation shell out will possible dampen sentiment for the stock, he said.
Bhatia lowered BofA’s earnings estimates for AmEx for 2020 and 2021 from $3.67 to $3.59 for every share and from $7.04 to $6.75, respectively, to replicate reduced billings development.
AXP Selling price Motion: Shares of American Categorical ended up down 2.68% at $95.84 at past check out Wednesday.
Most recent Ratings for AXP
| Day | Agency | Action | From | To |
|---|---|---|---|---|
| Sep 2020 | B of A Securities | Downgrades | Neutral | Underperform |
| Sep 2020 | B of A Securities | Maintains | Neutral | |
| Jul 2020 | B of A Securities | Maintains | Neutral |
Check out Additional Analyst Ratings for AXP
Perspective the Most recent Analyst Rankings
© 2020 Benzinga.com. Benzinga does not deliver expense advice. All legal rights reserved.